Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Apixaban 5 mg film-coated tablets in healthy Thai volunteers under fasting
TCTR20180308002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of apixaban (2 arms), sponsored by Bio-innova. Primary endpoint: Bioequivalence primary pharmacokinetic parameters. Planned start May 2018; status: not yet recruiting.
02
Drugs
apixaban
Beyond the preview
Go deeper on TCTR20180308002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180308002.